tell me about dihexa for me please (PNB-0408) | c-Met/HGFR Activator Dihexa

Some users argue that c-Met receptor downregulation could occur with sustained activation, suggesting periodic breaks

Spam, offensive content, impersonation, and private information will not be permitted

provided clinical expertise and contributed to final manuscript editing

Clinical practice guidelines suggest several scenarios where dose modification may be appropriate: Persistent gastrointestinal symptoms lasting beyond the first week of a new dose level may warrant extending that dose phase by an additional 2-4 weeks before further escalation

Its mechanism involves specific engagement of AMY1R and AMY3R in hindbrain and hypothalamic circuits that regulate energy homeostasis, leading to preferential fat mass reduction and altered hypothalamic gene expression profiles [2]